| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |